AQR Capital Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$282,000
-34.1%
5,048
-39.0%
0.00%0.0%
Q2 2022$428,000
-77.3%
8,278
-68.1%
0.00%
-75.0%
Q1 2022$1,888,000
-60.8%
25,985
-36.2%
0.00%
-55.6%
Q4 2021$4,812,000
-24.4%
40,700
-14.3%
0.01%
-25.0%
Q3 2021$6,369,000
+10.6%
47,477
+33.5%
0.01%
+20.0%
Q2 2021$5,760,000
+126.4%
35,576
+12.2%
0.01%
+150.0%
Q1 2021$2,544,000
+130.4%
31,704
+56.3%
0.00%
+100.0%
Q4 2020$1,104,000
+115.6%
20,290
-21.2%
0.00%
+100.0%
Q3 2020$512,000
+18.5%
25,744
+25.1%
0.00%0.0%
Q2 2020$432,000
-19.7%
20,575
-53.3%
0.00%0.0%
Q1 2020$538,000
-38.5%
44,023
-26.2%
0.00%0.0%
Q4 2019$875,000
+79.3%
59,637
+63.2%
0.00%0.0%
Q3 2019$488,000
+62.1%
36,538
+247.4%
0.00%
Q3 2018$301,000
+16.2%
10,519
+11.1%
0.00%
Q2 2018$259,000
-17.0%
9,464
-36.0%
0.00%
Q1 2018$312,000
-44.6%
14,791
-34.7%
0.00%
-100.0%
Q3 2017$563,000
+181.5%
22,640
+81.1%
0.00%
Q2 2017$200,00012,5030.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders